Pro-Dex Shares Outstanding 2010-2025 | PDEX

Pro-Dex shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pro-Dex Annual Shares Outstanding
(Millions of Shares)
2024 4
2023 4
2022 4
2021 4
2020 4
2019 4
2018 4
2017 4
2016 4
2015 4
2014 3
2013 3
2012 3
2011 3
2010 3
2009 3
Pro-Dex Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 3
2024-12-31 3
2024-09-30 3
2024-06-30 4
2024-03-31 4
2023-12-31 4
2023-09-30 4
2023-06-30 4
2023-03-31 4
2022-12-31 4
2022-09-30 4
2022-06-30 4
2022-03-31 4
2021-12-31 4
2021-09-30 4
2021-06-30 4
2021-03-31 4
2020-12-31 4
2020-09-30 4
2020-06-30 4
2020-03-31 4
2019-12-31 4
2019-09-30 4
2019-06-30 4
2019-03-31 4
2018-12-31 4
2018-09-30 4
2018-06-30 4
2018-03-31 4
2017-12-31 4
2017-09-30 4
2017-06-30 4
2017-03-31 4
2016-12-31 4
2016-09-30 4
2016-06-30 4
2016-03-31 4
2015-12-31 4
2015-09-30 4
2015-06-30 4
2015-03-31 4
2014-12-31 4
2014-09-30 4
2014-06-30 3
2014-03-31 3
2013-12-31 3
2013-09-30 3
2013-06-30 3
2013-03-31 3
2012-12-31 3
2012-09-30 3
2012-06-30 3
2012-03-31 3
2011-12-31 3
2011-09-30 3
2011-06-30 3
2011-03-31 3
2010-12-31 3
2010-09-30 3
2010-06-30 3
2010-03-31 3
2009-12-31 3
2009-09-30 3
2009-06-30 3
2009-03-31 3
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.131B $0.054B
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95